Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
- Conditions
- Quality of LifeCardiac FunctionAngina PectorisKuanzhong Aerosol
- First Posted Date
- 2024-06-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 150
- Registration Number
- NCT06480097
- Locations
- 🇨🇳
Nanfang hospital, Southern medical university, Guangzhou, Guangdong, China
Research on the Mechanisms of Treatment Non-response in Inflammatory Bowel Disease Based on Multi-omics Technology
Recruiting
- Conditions
- Inflammatory Bowel Diseases
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT06447870
- Locations
- 🇨🇳
NanFang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Long-term Outcomes of Duodenal Adenocarcinoma From a Large Cohort
Not yet recruiting
- Conditions
- Gastrointestinal Disease
- Interventions
- Procedure: Radical operation and perioperative therapy
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 400
- Registration Number
- NCT06443086
hAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation
Early Phase 1
Not yet recruiting
- Conditions
- Acute Graft Versus Host Disease
- Interventions
- Biological: Human amniotic epithelial stem cells（hAESCs）Biological: placebo (cell preservation solution)
- First Posted Date
- 2024-06-05
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 18
- Registration Number
- NCT06444022
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Phase 2
Not yet recruiting
- Conditions
- Small Cell Lung Cancer Extensive Stage
- Interventions
- Drug: PD-L1 inhibitor combined with apatinib
- First Posted Date
- 2024-05-28
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 40
- Registration Number
- NCT06429696
JNT Versus TNT to Guided OGT-overlap Oesophagojejunostomy
Not Applicable
Completed
- Conditions
- Gastric/Gastroesophageal Junction (g/Gej) Cancer
- Interventions
- Procedure: JNT Guided OGT-overlap OesophagojejunostomyProcedure: TNT Guided OGT-overlap Oesophagojejunostomy
- First Posted Date
- 2024-05-14
- Last Posted Date
- 2024-05-14
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 108
- Registration Number
- NCT06412575
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Donor Neutrophil Subsets to Predict the Risk of aGVHD
Active, not recruiting
- Conditions
- Acute Graft-versus-Host Disease
- First Posted Date
- 2024-05-01
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 260
- Registration Number
- NCT06394895
- Locations
- 🇨🇳
Nanfang Hospital, Southern Medical University, Guangzhou, Other (Non U.s.), China
To Optimize Therapeutic Procedures of DPMAS in ACLF Patients: a Prospective, Sigle Arm and Multicenter Study
Not yet recruiting
- Conditions
- Acute-On-Chronic Liver Failure
- Interventions
- Other: No intervention in this study
- First Posted Date
- 2024-04-22
- Last Posted Date
- 2024-04-22
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 2000
- Registration Number
- NCT06377774
A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease
Phase 4
Not yet recruiting
- Conditions
- Invasive Fungal Disease
- Interventions
- First Posted Date
- 2024-04-19
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 125
- Registration Number
- NCT06376201
Prospective Cohort Study of Complications and Outcomes in Cirrhosis
Recruiting
- Conditions
- Decompensated CirrhosisCMV ReactivationOvert Hepatic Encephalopathy
- Interventions
- Diagnostic Test: Test for CMV reactivation
- First Posted Date
- 2024-04-18
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Nanfang Hospital, Southern Medical University
- Target Recruit Count
- 660
- Registration Number
- NCT06374511
- Locations
- 🇨🇳
Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath